HDL Particle Size and Functional Heterogeneity.
作者信息
Fazio Sergio, Pamir Nathalie
机构信息
From the Center for Preventive Cardiology of the Knight Cardiovascular Institute, Department of Medicine, Oregon Health & Science University, Portland.
出版信息
Circ Res. 2016 Sep 2;119(6):704-7. doi: 10.1161/CIRCRESAHA.116.309506.
Abstract
摘要
相似文献
1
HDL Particle Size and Functional Heterogeneity.高密度脂蛋白颗粒大小与功能异质性
Circ Res. 2016 Sep 2;119(6):704-7. doi: 10.1161/CIRCRESAHA.116.309506.
2
HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.高密度脂蛋白颗粒大小是 ABCA1 介导的巨噬细胞细胞胆固醇流出的关键决定因素。
Circ Res. 2015 Mar 27;116(7):1133-42. doi: 10.1161/CIRCRESAHA.116.305485. Epub 2015 Jan 14.
3
Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients.贝特类药物和烟酸缓释剂对血脂异常患者高密度脂蛋白颗粒大小分布和胆固醇流出能力的影响差异。
J Clin Lipidol. 2013 Sep-Oct;7(5):414-22. doi: 10.1016/j.jacl.2013.06.007. Epub 2013 Jun 27.
4
[Nicotinic acid increases cellular transport of high density lipoprotein cholesterol in patients with hypoalphalipoproteinemia].[烟酸增加低脂蛋白血症患者高密度脂蛋白胆固醇的细胞转运]
Rev Med Chil. 2015 Sep;143(9):1097-104. doi: 10.4067/S0034-98872015000900001.
5
Novel formulation of a reconstituted high-density lipoprotein (CSL112) dramatically enhances ABCA1-dependent cholesterol efflux.新型重组成分高密度脂蛋白（CSL112）显著增强 ABCA1 依赖性胆固醇流出。
Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2202-11. doi: 10.1161/ATVBAHA.113.301981. Epub 2013 Jul 18.
6
CSL112 enhances biomarkers of reverse cholesterol transport after single and multiple infusions in healthy subjects.CSL112 单次和多次输注健康受试者后增强了胆固醇逆转运的生物标志物。
Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2106-14. doi: 10.1161/ATVBAHA.114.303720. Epub 2014 Jun 26.
7
Determinants of cholesterol efflux capacity in humans.胆固醇外排能力的人体决定因素。
Prog Lipid Res. 2018 Jan;69:21-32. doi: 10.1016/j.plipres.2017.12.001. Epub 2017 Dec 18.
8
Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).胆固醇流出能力、高密度脂蛋白颗粒数量与心血管事件发生率：来自JUPITER试验（他汀类药物在预防中的应用依据：一项评估瑞舒伐他汀的干预试验）的分析
Circulation. 2017 Jun 20;135(25):2494-2504. doi: 10.1161/CIRCULATIONAHA.116.025678. Epub 2017 Apr 27.
9
Increased plasma HDL cholesterol levels and biliary cholesterol excretion in hamster by LCAT overexpression.通过过表达卵磷脂胆固醇酰基转移酶（LCAT）增加仓鼠血浆高密度脂蛋白胆固醇水平及胆汁胆固醇排泄。
FEBS Lett. 2004 Jul 16;570(1-3):25-9. doi: 10.1016/j.febslet.2004.06.017.
10
HDL cholesterol efflux capacity and incident cardiovascular events.高密度脂蛋白胆固醇流出能力与心血管事件的发生
N Engl J Med. 2014 Dec 18;371(25):2383-93. doi: 10.1056/NEJMoa1409065. Epub 2014 Nov 18.
引用本文的文献
1
HDL from 36-h fasted participants potently promotes efflux of cholesteryl ester from activated microglia.来自禁食36小时参与者的高密度脂蛋白能有效促进活化小胶质细胞中胆固醇酯的流出。
Front Aging Neurosci. 2025 Aug 26;17:1629496. doi: 10.3389/fnagi.2025.1629496. eCollection 2025.
2
Association Between Diabetes and Site-Specific Cancer Risk: A Population-Based Cohort Study on the Differential Role of Metabolic Profiles.糖尿病与特定部位癌症风险之间的关联：一项基于人群队列研究代谢谱的差异作用
J Diabetes Res. 2025 Aug 11;2025:1271189. doi: 10.1155/jdr/1271189. eCollection 2025.
3
Effects of fasting on HDL particle function and size distribution.禁食对高密度脂蛋白（HDL）颗粒功能及大小分布的影响。
J Lipid Res. 2025 Jul 5;66(8):100859. doi: 10.1016/j.jlr.2025.100859.
4
Keratinocyte SR-B1 expression and targeting in cytokine-driven skin inflammation.角质形成细胞SR-B1在细胞因子驱动的皮肤炎症中的表达及靶向作用。
Commun Med (Lond). 2025 Apr 3;5(1):100. doi: 10.1038/s43856-025-00804-y.
5
Association of Small HDL Subclasses with Mortality Risk in Chronic Kidney Disease.小高密度脂蛋白亚类与慢性肾脏病死亡风险的关联
Antioxidants (Basel). 2024 Dec 11;13(12):1511. doi: 10.3390/antiox13121511.
6
Causal Association between Circulating Metabolites and Dementia: A Mendelian Randomization Study.循环代谢物与痴呆症之间的因果关联：一项孟德尔随机化研究。
Nutrients. 2024 Aug 28;16(17):2879. doi: 10.3390/nu16172879.
7
Causal association of lipoprotein-associated phospholipids on the risk of sepsis: a Mendelian randomization study.脂蛋白相关磷脂与败血症风险的因果关联：一项孟德尔随机化研究。
Front Endocrinol (Lausanne). 2024 Jan 11;14:1275132. doi: 10.3389/fendo.2023.1275132. eCollection 2023.
8
High-density lipoprotein cholesterol subfraction HDL2 is associated with improved endothelial function in systemic lupus erythematosus.高密度脂蛋白胆固醇亚组分 HDL2 与全身性红斑狼疮患者的内皮功能改善相关。
Lupus Sci Med. 2024 Jan 22;11(1):e001030. doi: 10.1136/lupus-2023-001030.
9
Crosstalk Between Cholesterol, ABC Transporters, and PIP2 in Inflammation and Atherosclerosis.胆固醇、ABC 转运蛋白和 PIP2 之间在炎症和动脉粥样硬化中的串扰。
Adv Exp Med Biol. 2023;1422:353-377. doi: 10.1007/978-3-031-21547-6_13.
10
Resolution of apolipoprotein A1 and A2 proteoforms: their cardiometabolic correlates and implications for future research.载脂蛋白 A1 和 A2 蛋白水解物的解析：其与心血管代谢的相关性及其对未来研究的意义。
Curr Opin Lipidol. 2022 Aug 1;33(4):264-269. doi: 10.1097/MOL.0000000000000840.
本文引用的文献
1
Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112: Effects on Cholesterol Efflux, Anti-Inflammatory and Antioxidative Activity.重组高密度脂蛋白（HDL）（CSL112）重塑HDL时产生的小HDL亚类中HDL功能增强：对胆固醇流出、抗炎和抗氧化活性的影响
Circ Res. 2016 Sep 2;119(6):751-63. doi: 10.1161/CIRCRESAHA.116.308685. Epub 2016 Jul 19.
2
Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.孤立性低高密度脂蛋白胆固醇是心血管疾病的危险因素吗？弗雷明汉后代研究的新见解。
Circ Cardiovasc Qual Outcomes. 2016 May;9(3):206-212. doi: 10.1161/CIRCOUTCOMES.115.002436. Epub 2016 May 10.
3
High-Density Lipoprotein Proteomic Composition, and not Efflux Capacity, Reflects Differential Modulation of Reverse Cholesterol Transport by Saturated and Monounsaturated Fat Diets.高密度脂蛋白蛋白质组组成，而非流出能力，反映了饱和脂肪和单不饱和脂肪饮食对胆固醇逆向转运的不同调节作用。
Circulation. 2016 May 10;133(19):1838-50. doi: 10.1161/CIRCULATIONAHA.115.020278. Epub 2016 Apr 14.
4
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease.清道夫受体BI中的罕见变异会升高高密度脂蛋白胆固醇并增加冠心病风险。
Science. 2016 Mar 11;351(6278):1166-71. doi: 10.1126/science.aad3517.
5
Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects.烟酸疗法可增加他汀类药物治疗患者的高密度脂蛋白颗粒数量及总胆固醇流出能力，但不会增加ABCA1特异性胆固醇流出能力。
Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):404-11. doi: 10.1161/ATVBAHA.115.306268. Epub 2015 Dec 17.
6
Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway.对近交系小鼠品系高密度脂蛋白（HDL）进行蛋白质组学分析表明，与HDL相关的载脂蛋白E（APOE）通过ABCA1途径降低胆固醇流出能力。
J Lipid Res. 2016 Feb;57(2):246-57. doi: 10.1194/jlr.M063701. Epub 2015 Dec 15.
7
Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone.靶向蛋白质组学鉴定对氧磷酶/芳基酯酶1（PON1）和载脂蛋白C为非诺贝特和罗格列酮治疗的糖尿病患者低α脂蛋白血症的潜在危险因素。
Mol Cell Proteomics. 2016 Mar;15(3):1083-93. doi: 10.1074/mcp.M115.054528. Epub 2015 Dec 14.
8
Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans.人类不同大小高密度脂蛋白中载脂蛋白A-I代谢的新途径。
Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):156-65. doi: 10.1161/ATVBAHA.115.306138. Epub 2015 Nov 5.
9
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study.高密度脂蛋白胆固醇外排能力与冠心病事件发生的相关性：一项前瞻性病例对照研究。
Lancet Diabetes Endocrinol. 2015 Jul;3(7):507-13. doi: 10.1016/S2213-8587(15)00126-6. Epub 2015 May 27.
10
Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity.高密度脂蛋白蛋白质组的炎症重塑会损害胆固醇流出能力。
J Lipid Res. 2015 Aug;56(8):1519-30. doi: 10.1194/jlr.M059089. Epub 2015 May 20.
Zotero 插件